BioFire Diagnostics LLC - Product Pipeline Analysis, 2017 Update

  • ID: 4372874
  • Company Profile
  • 30 pages
  • GlobalData
  • BioFire Diagnostics
1 of 5

FEATURED COMPANIES

  • Edge Biologicals, Inc.
  • Erba Diagnostics Inc
  • Nova Biomedical Corp
  • Remel Inc
  • MORE
Summary

BioFire Diagnostics LLC (BioFire Diagnostics), formerly Idaho Technology Inc, a subsidiary of bioMerieux SA, is a molecular diagnostics company that offers molecular biology products. The company offers solutions for healthcare providers, labs and customers. It provides respiratory rp, meningitis and encephalitis me, blood culture identification bcid and gastrointestinal gi panels to detect several pathogens including viruses, bacteria, parasites, yeast and antimicrobial resistance genes. BioFire Diagnostics offers filmarray tourch to molecular infection disease diagnostics. The company also offers filmarray Torch to fully integrated, random access system for syndromic infectious disease testing. It markets its products in clinical, research and military markets over through its parent organization. BioFire Diagnostics is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BioFire Diagnostics LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Edge Biologicals, Inc.
  • Erba Diagnostics Inc
  • Nova Biomedical Corp
  • Remel Inc
  • MORE
  • BioFire Diagnostics LLC Company Overview
  • BioFire Diagnostics LLC Company Snapshot
  • BioFire Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview
  • BioFire Diagnostics LLC - Pipeline Analysis Overview
  • BioFire Diagnostics LLC - Key Facts
  • BioFire Diagnostics LLC - Major Products and Services
  • BioFire Diagnostics LLC Pipeline Products by Development Stage
  • BioFire Diagnostics LLC Pipeline Products Overview
  • FilmArray Biothreat-E Test
  • FilmArray Biothreat-E Test Product Overview
  • FilmArray Direct Sepsis Panel
  • FilmArray Direct Sepsis Panel Product Overview
  • FilmArray Febrile Infant Panel
  • FilmArray Febrile Infant Panel Product Overview
  • FilmArray NGDS BT-E Assay
  • FilmArray NGDS BT-E Assay Product Overview
  • FilmArray Pneumonia Pathogen Panel
  • FilmArray Pneumonia Pathogen Panel Product Overview
  • FilmArray STD Panel
  • FilmArray STD Panel Product Overview
  • BioFire Diagnostics LLC - Key Competitors
  • BioFire Diagnostics LLC - Key Employees
  • BioFire Diagnostics LLC - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • BioFire Diagnostics LLC, Recent Developments
  • Jun 01, 2017: bioMérieux receives FDA Clearance for BioFire’s FilmArray Respiratory Panel 2 (RP2)
  • Nov 04, 2016: Protecting our troops from disease: FDA approves early detection and diagnosis device
  • Oct 11, 2016: FilmArray Respiratory Panel EZ is CLIA waived by the FDA
  • Apr 08, 2016: FilmArray Torch is now FDA cleared with all 4 existing FilmArray Panels and the system gets CE marked
  • Feb 25, 2016: BioFire Receives FDA Clearance for FilmArray Torch with FilmArray Respiratory Panel and Submits Special 510(k) Applications for Use with additional FilmArray Panels
  • Jan 26, 2016: BioFire’s FilmArray Meningitis/Encephalitis Panel Gets CE Marked
  • Jan 12, 2016: BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray Torch, the New High Throughput FilmArray System with FilmArray Respiratory Panel
  • Oct 09, 2015: BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray Meningitis/Encephalitis panel continuing its extremely favorable business momentum
  • Oct 08, 2015: FDA allows marketing of the first nucleic acid-based test to detect multiple pathogens from a single sample of cerebrospinal fluid
  • Sep 24, 2015: BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray Ebola Test by the World Health Organization
  • Appendix
  • Methodology
List of Tables
  • BioFire Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview
  • BioFire Diagnostics LLC Pipeline Products by Equipment Type
  • BioFire Diagnostics LLC Pipeline Products by Indication
  • BioFire Diagnostics LLC, Key Facts
  • BioFire Diagnostics LLC, Major Products and Services
  • BioFire Diagnostics LLC Number of Pipeline Products by Development Stage
  • BioFire Diagnostics LLC Pipeline Products Summary by Development Stage
  • FilmArray Biothreat-E Test - Product Status
  • FilmArray Biothreat-E Test - Product Description
  • FilmArray Direct Sepsis Panel - Product Status
  • FilmArray Direct Sepsis Panel - Product Description
  • FilmArray Febrile Infant Panel - Product Status
  • FilmArray Febrile Infant Panel - Product Description
  • FilmArray NGDS BT-E Assay - Product Status
  • FilmArray NGDS BT-E Assay - Product Description
  • FilmArray Pneumonia Pathogen Panel - Product Status
  • FilmArray Pneumonia Pathogen Panel - Product Description
  • FilmArray STD Panel - Product Status
  • FilmArray STD Panel - Product Description
  • BioFire Diagnostics LLC, Key Employees
  • Glossary
List of Figures
  • BioFire Diagnostics LLC Pipeline Products by Equipment Type
  • BioFire Diagnostics LLC Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Remel Inc
  • Nova Biomedical Corp
  • Erba Diagnostics Inc
  • Edge Biologicals, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll